Skip to content

BIOSTEM U.S. CORP

CIK 0001455380

← back to feed
Revenue (TTM)
$5.61K
+544.2% YoY Q3 Dec 2012
Net Income (TTM)
−$3.84M
−1,758.0% YoY Q3 Dec 2012
EPS Diluted (TTM)
—
Q3 Dec 2012
Gross Margin
92.5%
Q3 Dec 2012
Operating Margin
—
Q3 Dec 2012
Net Margin
-68,475.6%
Q3 Dec 2012
Free Cash Flow (TTM)
—
Q3 Dec 2012
Cash
—
Q3 Dec 2012
Total Debt
—
Q3 Dec 2012
Shares Outstanding
114.21M sh
Q3 Dec 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings